Medical Health & Life Science Research News

New report shares details about the biologics global market 2017

New report shares details about the biologics global market 2017

The global biologics market was estimated to be around $210 billion as of 2016. It made up around 20% of the overall pharmaceuticals market in 2016. The biologics was the second largest market, following the pharmaceutical drugs market in the global pharmaceutical market in 2016.

- Advertisement -

- Restart your WhaTech membership at anytime. -

ACCESS REPORT @ www.thebusinessresearchcompany.com…obal-report-2017/ Make an Inquiry about this news

The Biologics Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global satellite and telecommunications resellers sector.

Where is the largest and fastest growing market for the biologics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biologics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

- Advertisement -

- Restart your WhaTech membership at anytime. -
It places the market within the context of the wider pharmaceutical market, and compares it with other markets.
• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
• Market segmentations break down market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets.

It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
• Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
• The biologics market section of the report gives context. It compares the biologics market with other segments of the pharmaceutical market by size and growth, historic and forecast.

It analyses Expenditure Per Capita, The biologics Indicators Comparison.
• The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.

Reasons To Access

  • Outperform competitors using accurate up to date demand-side dynamics information.
    • Identify growth segments for investment.
    • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
    • Create regional and country strategies on the basis of local data and analysis.
    • Stay abreast of the latest customer and market research findings
    • Benchmark performance against key competitors.
    • Develop strategies based on likely future developments.
    • Utilize the relationships between key data sets for superior strategizing.
    • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
    • Gain a global perspective on the development of the market.
    • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Scope

Markets Covered: Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines

Companies Mentioned: Johnson & Johnson, Pfizer Inc., Novartis AG, Abbvie, and Sanofi

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Biologics Indicators Comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

 www.thebusinessresearchcompany.com…lobal_report_2017 Make an Inquiry about this news

  1. Biologics Market Characteristics; 

    2. Biologics Market Size And Growth; 
    2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market; 

    3. Pestle Analysis; 
    3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental; 

    4. Biologics Market Customer Information; 

    5. Biologics Market Segmentation; 
    5.1. Global Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 5.2. Global Biologics Market, 2012 - 2020, Historic And Forecast, By Segment; 5.3 Global Biologics Market Trends And Strategies; 5.4 Global Biologics Market Compared With Similar Markets, 2016; 5.5 Global Biologics Market Compared With Similar Markets, 2012 – 2020, Historic and Forecast; 5.6 Biologics Market Compared With Similar Markets, 2016, By Region; 5.7 Biologics Market Compared With Similar Markets, 2016, By Country; 5.8 Therapeutic Proteins; 5.8.1. Market Characteristics; 5.8.2. Global Internet Broadcasting & Publishing Market, 2016, By Segment; 5.8.3. Market Trends And Strategies; 5.9 Monoclonal Antibodies (MABS); 5.9.1. Market Characteristics; 5.9.2. Global Internet Broadcasting & Publishing Market, 2016, By Segment; 5.9.3. Market Trends And Strategies; 5.10 Vaccines; 5.9.1. Market Characteristics; 5.10.2. Global Internet Broadcasting & Publishing Market, 2016, By Segment; 5.10.3. Market Trends And Strategies; 

    6. Biologics Market Regional And Country Analysis; 
    6.1. Global Biologics Market, 2016, By Region; 6.2. Global Biologics Market, 2012 - 2020, Historic And Forecast, By Region; 6.3. Biologics Market, 2016, By Country; 6.4. Biologics Market, 2012 - 2020, Historic And Forecast, By Country; 6.5. Global Healthcare Market Segments, 2016, By Region; 6.6. Global Pharmaceuticals Market Segments, 2016, By Region; 6.7. Global Healthcare Market Segments, 2016, By Country; 6.8. Global Pharmaceuticals Market Segments, 2016, By Country;

    7. Global Biologics Market Comparison With Macro Economic Factors; 
    7.1. Biologics Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Biologics Expenditure, Global; 

    8. Biologics Market Comparison With Macro Economic Factors Across Countries; 
    8.1. Biologics Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Biologics Expenditure, By Country; 

    9. Biologics Market Comparison With Industry Metrics; 
    9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Biologics Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Biologics Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Number Of Employees In Pharmaceutical Industry, 2016, By Country; 9.6. Global Biologics Market Revenue Versus Number Of Employees In Pharmaceutical Industry, 2016, By Country; 9.7. Global Average Spending On R&D/Product Development, 2016, By Country; 9.8. Global Biologics Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.9. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.10. Global Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.11. Global Generic & Branded Sales Proportion By Country (Volume), 2016, By Country; 9.12. Global Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2016, By Country; 9.13. Global Number Of Pharmacies, 2016, By Country; 9.14. Global Biologics Market Revenue Versus Number Of Pharmacies, 2016, By Country; 9.15. Global New Drug Approvals, 2016, By Country; 9.16. Global Biologics Market Revenue Versus New Drug Approvals, 2016, By Country; 9.17. Prevalent Cases Of Thalassemia, 2014, By Country; 9.18. Global Number Of General Practitioners 2016, By Country; 9.19. Global Biologics Market Revenue Versus Number Of General Practitioners, 2016, By Country; 

    10. Asia-Pacific Biologics Market; 
    10.1.1. Asia-Pacific Biologics Market Overview; 10.1.2. Asia-Pacific Biologics Historic Market, 2012 - 2016; 10.1.3. Asia-Pacific Biologics Forecast Market, 2016 - 2020; 10.1.4. Asia-Pacific Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 10.2. Asia-Pacific Biologics Market: Country Analysis; 10.3. China Biologics Market; 10.3.1. China Biologics Market Overview; Average Salaries Of Pharmacists; 10.3.2. China Biologics Historic Market, 2012 - 2016; 10.3.3. China Biologics Forecast Market, 2016 - 2020; 10.3.4. China Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 10.3.5. China Biologics Percentage Of GDP, 2012 - 2020; 10.3.6. China Per Capita Average Biologics Expenditure, 2012 - 2020; 10.4. India Biologics Market; 10.4.1. India Biologics Market Overview; Average Salaries Of Pharmacists; 10.4.2. India Biologics Historic Market, 2012 - 2016; 10.4.3. India Biologics Forecast Market, 2016 - 2020; 10.4.4. India Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 10.4.5. India Biologics Percentage Of GDP, 2012 - 2020; 10.4.6. India Per Capita Average Biologics Expenditure, 2012 - 2020; 10.5. Japan Biologics Market; 10.5.1. Japan Biologics Market Overview; Average Salaries Of Pharmacists; 10.5.2. Japan Biologics Historic Market, 2012 - 2016; 10.5.3. Japan Biologics Forecast Market, 2016 - 2020; 10.5.4. Japan Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 10.5.5. Japan Biologics Percentage Of GDP, 2012 - 2020; 10.5.6. Japan Per Capita Average Biologics Expenditure, 2012 - 2020; 10.5.7. Japan Biologics Market Comparison With Industry Metrics; 10.5.7.1. Japan Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 10.5.7.2. Japan Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 10.6. Australia Biologics Market; 10.6.1. Australia Biologics Historic Market, 2012 - 2016; 10.6.2. Australia Biologics Forecast Market, 2016 - 2020; 10.6.3. Australia Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 10.6.4. Australia Biologics Percentage Of GDP, 2012 - 2020; 10.6.5. Australia Per Capita Average Biologics Expenditure, 2012 - 2020; 
  2. ...CONTINUED
    KNOW MORE WITH SAMPLE [email protected] www.thebusinessresearchcompany.com…lobal_report_2017 Make an Inquiry about this news

 

For more information:

Make an Inquiry about this report HERE!
  • www.thebusinessresearchcompany.com…lobal-report-2017
  • www.thebusinessresearchcompany.com…lobal_report_2017
  • www.thebusinessresearchcompany.com…lobal_report_2017